Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066942
Filing Date
2025-05-08
Accepted
2025-05-08 16:10:01
Documents
67
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tyra-20250331.htm   iXBRL 10-Q 1684167
2 EX-31.1 tyra-ex31_1.htm EX-31.1 18418
3 EX-31.2 tyra-ex31_2.htm EX-31.2 18615
4 EX-32.1 tyra-ex32_1.htm EX-32.1 10459
5 EX-32.2 tyra-ex32_2.htm EX-32.2 10422
  Complete submission text file 0000950170-25-066942.txt   7821604

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tyra-20250331.xsd EX-101.SCH 1110804
70 EXTRACTED XBRL INSTANCE DOCUMENT tyra-20250331_htm.xml XML 1515050
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40800 | Film No.: 25926120
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)